Tag: buccal drug delivery system market trends

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

2024-2033 Forecast: What is the Projected Growth Rate for the Buccal Drug Delivery System Market?

The buccal drug delivery system market is expanding rapidly, projected to grow from $3.28 billion in 2023 to $3.64 billion in 2024 at a CAGR of 11.0%, driven by early innovations in drug delivery, industry adoption, clinical studies, disease-specific applications, and market penetration strategies.

The buccal drug delivery system market is expected to grow to $5.43 billion by 2028, at a CAGR of 10.5%. Growth is attributed to patient-centric drug delivery, an aging population, demand for targeted therapies, biologics, and regulatory support. Key trends include patient convenience, advancements in drug formulations, a rise in chronic diseases, pediatric and geriatric care, and enhanced bioavailability.

Claim Your Free Sample of the Global Buccal Drug Delivery System Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp

What Are the Main Drivers Behind the Growth of the buccal drug delivery system Market?

The buccal drug delivery systems market is poised for growth due to the rising prevalence of chronic diseases worldwide. Chronic diseases like cancer, heart disease, stroke, diabetes, and arthritis necessitate continuous medical care and management. Buccal drug delivery systems offer an effective means of administering drugs to patients suffering from such conditions. Data from the World Health Organization highlights the significant global burden of non-communicable diseases, with millions of deaths attributed to chronic illnesses annually. This prevalence of chronic diseases underscores the importance of buccal drug delivery systems, with the market valued at $6.2 billion in 2023 and projected to reach $10.8 billion by 2028.

What Are the Primary Segments of the Buccal Drug Delivery System Market?

1) By Type: Sublingual, Buccal Tablets and Lozenges, Oral Sprays

2) By Application: Pain Management, Smoking Cesstion, Angina Pectoris

3) By End-User: Hospitals, Ambulatory Centers, Other End-Users

Which Trends Are Revolutionizing the 128 Market?

Investments in injectable drug delivery systems are becoming increasingly prominent in the buccal drug delivery systems market, as major pharmaceutical companies seek to reinforce their market positions. For instance, in September 2021, Novartis, a Switzerland-based pharmaceutical company, invested approximately $40 million in Credence MedSystems, a US-based developer of innovative drug delivery systems. This investment aims to bolster the production of injectable drug delivery systems, reflecting the growing importance of advanced delivery technologies in the pharmaceutical industry.

Order Now for Fast Delivery of Your Buccal Drug Delivery System Market Report!

https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report

Which Geographical Regions Are Pioneering Growth in the Buccal Drug Delivery System Market?

North America was the largest region in the buccal drug delivery systems market share in 2023. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Buccal Drug Delivery System Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the buccal drug delivery system market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Buccal Drug Delivery System Market Include

1. Buccal Drug Delivery System Market Executive Summary

2. Buccal Drug Delivery System Market Segments

3. Buccal Drug Delivery System Market Size And Template Market Growth Rate

4. Key Buccal Drug Delivery System Market Trends

5. Major Buccal Drug Delivery System Market Drivers

……

25. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

26. Top Buccal Drug Delivery System Companies

27. Buccal Drug Delivery System Market Opportunities And Strategies

28. Buccal Drug Delivery System Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Global Implantable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Injectable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 The buccal drug delivery system market has experienced rapid growth in recent years, with the market size reaching $3.28 billion in 2023 and projected to grow to $3.64 billion in 2024, showcasing a noteworthy CAGR of 11.0%. Looking ahead, the forecast indicates continued expansion, with an estimated market size of $5.43 billion by 2028 and a CAGR of 10.5%. Factors contributing to this growth include patient-centric drug delivery, an aging population, demand for targeted therapies, regulatory support, and investments in research and development.

Rising Chronic Diseases Propel Market Growth

• Prevalence of Chronic Diseases: The buccal drug delivery systems market is driven by the increasing prevalence of chronic diseases such as cancer, heart disease, stroke, diabetes, and arthritis.
• Non-Communicable Diseases Impact: According to the World Health Organization, 74% of the 41 million deaths caused by non-communicable diseases annually are attributed to chronic diseases.
• Continuous Nutrition and Care: Chronic diseases require continuous nutrition and medical care, making buccal drug delivery systems an effective solution.

Key Market Players

Major companies contributing to the buccal drug delivery system market include Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Catalent Inc., and many others. These companies play a crucial role in advancing drug delivery innovations and addressing various disease-specific applications.

Increasing Focus On Product Launches

• Product Innovation: Major companies focus on launching new products to enhance their market presence.
• Melatonin Oral Spray: Arlak Biotech launched a melatonin oral spray in February 2023, offering an easy and effective solution for improving sleep quality. The spray’s oral absorption provides a quick and simple approach to addressing sleep-related issues.

View More On The Buccal Drug Delivery System Market Report 2024 – https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report

Strategic Acquisition By DifGen Pharmaceuticals

• Acquisition Move: In April 2023, DifGen Pharmaceuticals LLC acquired Aveva Drug Delivery Services Inc.
• Enhanced Capabilities: This strategic acquisition aims to enhance DifGen’s research and development capabilities and strengthen its supply chain for complex dosage forms, focusing on buccal drug delivery systems.

Market Segmentation

The buccal drug delivery system market is segmented based on:

1. Type: Sublingual, Buccal Tablets and Lozenges, Oral Sprays
2. Application: Pain Management, Smoking Cessation, Angina Pectoris
3. End-User: Hospitals, Ambulatory Centers, Other End-Users

Regional Trends

• North America Dominance: North America emerged as the largest region in the buccal drug delivery systems market in 2023.

Future Trends and Outlook

• Patient Convenience and Compliance:Future trends in the buccal drug delivery system market include a strong focus on patient convenience and compliance.
• Advancements in Drug Formulations: Continuous advancements in drug formulations contribute to the market’s growth.
• Rise in Chronic Diseases: The increasing incidence of chronic diseases continues to be a driving factor for the market.
• Pediatric and Geriatric Care: Specialized drug delivery systems for pediatric and geriatric populations are gaining prominence.
• Enhanced Bioavailability: Strategies to enhance drug bioavailability contribute to the effectiveness of buccal drug delivery systems.

Conclusion
The buccal drug delivery system market’s rapid growth is intricately linked to addressing the challenges posed by chronic diseases and the commitment of key players to innovation. As the market continues to evolve, a focus on patient-centric solutions, advancements in drug formulations, and specialized care for different age groups will shape the future of buccal drug delivery systems. With a significant market size and a trajectory of continuous growth, the buccal drug delivery system market remains a crucial player in the pharmaceutical industry.

Request A Sample Of The Global Buccal Drug Delivery System Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=8290&type=smp